What we offer
Technology solution to automate monitoring, intake, processing, validation, seriousness assessment, and quality checks of safety-related cases, thereby driving operational efficiencies and meaningful outcomes in PV operations
Who is it for
Heads of drug safety and pharmacovigilance teams
Why it’s important
Improve quality, traceability, and reconciliation
Reduce costs of pharmacovigilance and case processing
Reduce turnaround time for cases
How we deliver
Process
Using NEXT Adverse Events Management, AE/PQC/MI agents are able to leverage AI-enabled voice-to-text conversion, intelligent call flow assistance with automated data capture, and review processes to enable quicker, more accurate, and noise-free case intake. The tool can also detect and auto-populate relevant AE information from social media and literature articles for case creation. In case processing, the tool reduces manual effort by auto-populating data fields from various structured, semi-structured, and unstructured sources, followed by thorough duplicate checks and accurate triaging and validation.
Additionally, our large multidisciplinary talent pool of PV and product safety experts have extensive knowledge of various therapy areas and regulatory requirements to perform medical reviews and safety assessments.
What makes us different
Domain-led technology-driven ready-to-deploy accelerators
End-to-end automation of PV case intake and processing
